Italia markets open in 29 minutes

TEVA Aug 2024 10.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
7,050,00 (0,00%)
In data: 01:36PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente7,05
Aperto7,05
Denaro0,00
Domanda0,00
Prezzo d'esercizio10,00
Scadenza2024-08-16
Min-Max giorno7,05 - 7,05
Contratto - Min-MaxN/D
Volume100
Open InterestN/D
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.